CellFE, Inc. Market Research Report
Company Overview
- Name: CellFE, Inc.
- Mission: To create a world where everyone has access to lifesaving cell therapies.
- Year Founded: No information is available
- Founders: No information is available
- Key People:
- Alla Zamarayeva, PhD - CEO & Co-founder
- Todd Sulchek, PhD - CSO & Co-founder
- Andrew Levitch - CFO
- Alex Alexeev, PhD - CTO & Co-founder
- Leo Fomin - VP of Product Development
- Sewoon Han, PhD - Head of Engineering
- Paul Carman - Head of Sales
- Chih-Wen Ni, PhD - Head of Science
- Headquarters: 1000 Atlantic Ave., Suite 104, Alameda, CA 94501
- Number of Employees: No information is available
- Revenue: No information is available
- Notable for: Developing the Infinity MTx platform, a microfluidics-based cellular engineering technology for research and process development of cell therapies.
Products
Infinity MTx Platform
- Product Description:
- The Infinity MTxTM instrument is a benchtop device designed for research and process development of cell therapies using microfluidics technology.
- Key Features:
- Gentle Process: Ensures engineered cells remain healthy and recover quickly for downstream applications.
- Reliable Delivery: Transfects challenging cell types with a variety of payloads.
- Exceptional Performance: High yields of transfected cells with robust proliferative capacity.
- Streamlined Workflow: Easy optimization without the need for specific media, buffers, or chemical additives.
- Small Footprint: Fits inside a biological safety cabinet or on a laboratory benchtop.
- Rapid Processing: Samples are processed in less than 10 milliseconds.
- User-Friendly: Plug-and-play setup with intuitive software for creating and editing protocols.
- Flexible: Processes up to eight samples in one run.
- Convenient: Includes bar code reader, NFC tag, and features for run history analysis.
Infinity MPAs (Microfluidic Processing Assemblies)
- Product Description:
- Designed for use with the Infinity MTx instrument, each MPA includes eight single-use processing units.
- Key Features:
- Optimize Your Protocol: Infinity Optimizer MPA consists of processing units with varying ridge gap sizes to optimize protocols.
- Scale with Consistency: Standard Infinity MPA uses microfluidic chips with single ridge gap sizes for standard protocols once optimized.
Recent Developments
New Partnerships and Financial Milestones:
- Series A Financing:
- Raised $22 million in Series A financing led by M Ventures, with participation from Great Point Ventures, Riverine Ventures, and existing investors.
Events and Presentations:
- May 2024 Conference:
- CEO Alla Zamarayeva, PhD, to present at the International Society of Gene & Cell Therapy (ISCT) Annual Meeting from May 29-June 1, 2024, in Vancouver, BC.
- CSO Todd Sulchek, PhD, to present at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting from May 7-11, 2024, in Baltimore, MD.
- BIO2022:
- Unveiled research scale microfluidics-based cell engineering platform at the BIO International Convention.
Product and Technology Enhancement:
- Infinity Platform Development:
- Continued innovation in microfluidics technology to support high yields, scalability, superior cell health, and complex genome editing without the need for viral vectors.
Team Expansion:
- Board of Directors:
- Mike Rice, a veteran in life science tools, has joined the board of directors.
Key Impact Metrics
- Viability: >90% with superior cell health and functionality.
- Payload Delivery: 10+ kb for any cell type.
- Scalability: From 1 million to billions of cells, scaling from discovery to commercial manufacturing.
- Processing Time: 1-2 days, including complex editing.
- Viral Vectors: No viral vectors required.
Intellectual Property
- Patents:
- US 10717084
- US 11198127
- US 11268892
- US 11668638
- US 11788050
- US 11925934
- US 8356714
- CN 110198785
- CN 117015596
- JP 7084393
Contact Information
- Address:
- CellFE, Inc.
- 1000 Atlantic Ave., Suite 104
- Alameda, CA 94501
- Email: info@cellfebiotech.com
© 2024 CellFE, Inc. All rights reserved.
Privacy Policy | Terms of Use